Literature DB >> 30207801

Primary central nervous system lymphoma with no enhancement initially and no significant progression over a long term: a case report and review of the literature.

Ning-Ning Hu1, Man-Man Zhang2, Yan-Yan Chen2, Bei-Lei Zhu2.   

Abstract

Primary central nervous system lymphoma, a rare primary intracranial tumor, is highly malignant and usually associated with poor prognosis. Recent years, owing to the remarkable progress in intervention techniques, survival time reported has been significantly prolonged. Strategies targeting alleviation and remission are primarily depended on the early diagnosis. However, due to the heterogeneity of the clinical symptoms and imaging features, the disease is frequently misdiagnosed especially in the early phase, rendering a delay of optimal treatment. Herein, we reported the case of a 61-year-old man who was initially misdiagnosed as demyelinating encephalopathy. MRI images showed multifocal lesions across the cerebral cortex and deep white matter, which are not strengthened on contrast enhancements. In respect of clinical symptoms, no significant progress was observed over about 11 months. Finally, the diagnosis was revealed by brain biopsy. After reviewing all the images of the patient, we found that the corpus callosum was involved early in the course of the disease. Therefore, for multifocal intracranial lesions involving the corpus callosum, we should always be vigilant about the possibility of primary central nervous system lymphoma. Histopathological examination of brain biopsy is helpful for early definitive diagnosis.

Entities:  

Keywords:  Lymphoma; biopsy; central nervous system; corpus callosum; magnetic resonance imaging

Mesh:

Year:  2018        PMID: 30207801     DOI: 10.1080/00207454.2018.1523159

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  1 in total

1.  The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series.

Authors:  Stephen G Bowden; Daniel N Munger; Jaclyn Thiessen; S Cody Schoettler Woll; Seunggu J Han; Edward A Neuwelt; Ramon F Barajas; Prakash Ambady
Journal:  CNS Oncol       Date:  2020-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.